Dok1 and Dok2 proteins regulate natural killer cell development and function

EMBO Journal

Volumn 33, Issue 17, 2014, Pages 1928-1940

  Celis Gutierrez, Javier ^a,b,c,d   Boyron, Marilyn ^d,e   Walzer, Thierry ^d,e,f   Pandolfi, Pier Paolo ^g   Jonjic̈, Stipan ^h   Olive, Daniel ^a,b,c,d   Dalod, Marc ^d,e   Vivier, Eric ^d,e,i   Nunès, Jacques A ^a,b,c,d  

^a INSERM   (France)

^b INSTITUT PAOLI CALMETTES   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

^e CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^f UNIVERSITÉ DE LYON   (France)

^g HARVARD MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF RIJEKA   (Croatia)

ⁱ HÔPITAL DE LA CONCEPTION   (France)

Author keywords

adaptor proteins; cell signaling; cytokine production; Dok molecules; natural killer cells

Indexed keywords

ADAPTOR PROTEIN; DOK1 PROTEIN; DOK2 PROTEIN; PROTEIN DERIVATIVE; PROTEIN TYROSINE KINASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MOUSE; NATURAL KILLER CELL; NEGATIVE FEEDBACK; NONHUMAN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ADAPTOR PROTEINS; CELL SIGNALING; CYTOKINE PRODUCTION; DOK MOLECULES; NATURAL KILLER CELLS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; DNA-BINDING PROTEINS; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; PHOSPHOPROTEINS; RNA-BINDING PROTEINS;

EID: 84906834647     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201387404     Document Type: Article

References (38)

1. Acuto O, Di Bartolo V, Michel F, (2008) Tailoring T-cell receptor signals by proximal negative feedback mechanisms. Nat Rev Immunol 8: 699-712
2. Arase H, Mocarski ES, Campbell AE, Hill AB, Lanier LL, (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326
3. Banh C, Miah SM, Kerr WG, Brossay L, (2012) Mouse natural killer cell development and maturation are differentially regulated by SHIP-1. Blood 120: 4583-4590
4. Baranek T, Manh TP, Alexandre Y, Maqbool MA, Cabeza JZ, Tomasello E, Crozat K, Bessou G, Zucchini N, Robbins SH, Vivier E, Kalinke U, Ferrier P, Dalod M, (2012) Differential responses of immune cells to type I interferon contribute to host resistance to viral infection. Cell Host Microbe 12: 571-584
5. Chiossone L, Chaix J, Fuseri N, Roth C, Vivier E, Walzer T, (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113: 5488-5496
6. Di Santo JP, Vosshenrich CA, (2006) Bone marrow versus thymic pathways of natural killer cell development. Immunol Rev 214: 35-46
7. Dong S, Corre B, Foulon E, Dufour E, Veillette A, Acuto O, Michel F, (2006) T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok2, SHIP-1, and Grb-2. J Exp Med 203: 2509-2518
8. Firaguay G, Nunes JA, (2009) Analysis of signaling events by dynamic phosphoflow cytometry. Sci Signal 2: pl3
9. Gerard A, Favre C, Garcon F, Nemorin JG, Duplay P, Pastor S, Collette Y, Olive D, Nunes JA, (2004) Functional interaction of RasGAP-binding proteins Dok1 and Dok2 with the Tec protein tyrosine kinase. Oncogene 23: 1594-1598
10. Gerard A, Ghiotto M, Fos C, Guittard G, Compagno D, Galy A, Lemay S, Olive D, Nunes JA, (2009) Dok4 is a novel negative regulator of T cell activation. J Immunol 182: 7681-7689
11. Guittard G, Gerard A, Dupuis-Coronas S, Tronchere H, Mortier E, Favre C, Olive D, Zimmermann P, Payrastre B, Nunes JA, (2009) Cutting edge: Dok1 and Dok2 adaptor molecules are regulated by phosphatidylinositol 5-phosphate production in T cells. J Immunol 182: 3974-3978
12. Hayakawa Y, Smyth MJ, (2006) CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 176: 1517-1524
13. Inoue A, Yasuda T, Yamamoto T, Yamanashi Y, (2007) Dok1 is a positive regulator of IL-4 signalling and IgE response. J Biochem 142: 257-263
14. Kim S, Iizuka K, Kang HS, Dokun A, French AR, Greco S, Yokoyama WM, (2002) In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 3: 523-528
15. Le Drean E, Vely F, Olcese L, Cambiaggi A, Guia S, Krystal G, Gervois N, Moretta A, Jotereau F, Vivier E, (1998) Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases. Eur J Immunol 28: 264-276
16. Lee CM, Jung ID, Noh KT, Lee JS, Park JW, Heo DR, Park JH, Chang JH, Choi IW, Kim JS, Shin YK, Park SJ, Han MK, Lee CG, Cho WK, Park YM, (2012) An essential regulatory role of downstream of kinase-1 in the ovalbumin-induced murine model of asthma. PLoS ONE 7: e34554
17. Liu D, Peterson ME, Long EO, (2012) The adaptor protein Crk controls activation and inhibition of natural killer cells. Immunity 36: 600-611
18. Ljunggren HG, Malmberg KJ, (2007) Prospects for the use of NK cells in immunotherapy of human cancer. Nat Rev Immunol 7: 329-339
19. Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HWt, (2005) Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 79: 661-667
20. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S, (2013) Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu Rev Immunol 31: 227-258
21. Mashima R, Hishida Y, Tezuka T, Yamanashi Y, (2009) The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev 232: 273-285
22. Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult ML, Chetaille B, Firaguay G, Pastor S, Guillaume Y, Wang Q, Hirsch I, Nunes JA, Olive D, (2011) Differential role for CD277 as a co-regulator of the immune signal in T and NK cells. Eur J Immunol 41: 3443-3454
23. Miletic A, Krmpotic A, Jonjic S, (2013) The evolutionary arms race between NK cells and viruses: who gets the short end of the stick? Eur J Immunol 43: 867-877
24. Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E, (2011) Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci USA 108: 18324-18329
25. Nemorin JG, Laporte P, Berube G, Duplay P, (2001) p62dok negatively regulates CD2 signaling in Jurkat cells. J Immunol 166: 4408-4415
26. Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, Cordon-Cardo C, Pandolfi PP, (2004) Role of Dok1 and Dok2 in leukemia suppression. J Exp Med 200: 1689-1695
27. Nunes JA, Truneh A, Olive D, Cantrell DA, (1996) Signal transduction by CD28 costimulatory receptor on T cells. B7-1 and B7-2 regulation of tyrosine kinase adaptor molecules. J Biol Chem 271: 1591-1598
28. Orr MT, Lanier LL, (2010) Natural killer cell education and tolerance. Cell 142: 847-856
29. Slavuljica I, Busche A, Babic M, Mitrovic M, Gasparovic I, Cekinovic D, Markova Car E, Pernjak Pugel E, Cikovic A, Lisnic VJ, Britt WJ, Koszinowski U, Messerle M, Krmpotic A, Jonjic S, (2010) Recombinant mouse cytomegalovirus expressing a ligand for the NKG2D receptor is attenuated and has improved vaccine properties. J Clin Invest 120: 4532-4545
30. Smith HR, Heusel JW, Mehta IK, Kim S, Dorner BG, Naidenko OV, Iizuka K, Furukawa H, Beckman DL, Pingel JT, Scalzo AA, Fremont DH, Yokoyama WM, (2002) Recognition of a virus-encoded ligand by a natural killer cell activation receptor. Proc Natl Acad Sci USA 99: 8826-8831
31. Vey N, Bourhis JH, Boissel N, Bordessoule D, Prebet T, Charbonnier A, Etienne A, Andre P, Romagne F, Benson D, Dombret H, Olive D, (2012) A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission. Blood 120: 4317-4323
32. Vivier E, Nunes JA, Vely F, (2004) Natural killer cell signaling pathways. Science 306: 1517-1519
33. Vivier E, Ugolini S, Blaise D, Chabannon C, Brossay L, (2012) Targeting natural killer cells and natural killer T cells in cancer. Nat Rev Immunol 12: 239-252
34. Vivier E, Ugolini S, Nunes JA, (2013) ADAPted secretion of cytokines in NK cells. Nat Immunol 14: 1108-1110
35. Yagita M, Huang CL, Umehara H, Matsuo Y, Tabata R, Miyake M, Konaka Y, Takatsuki K, (2000) A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation. Leukemia 14: 922-930
36. Yarkoni Y, Getahun A, Cambier JC, (2010) Molecular underpinning of B-cell anergy. Immunol Rev 237: 249-263
37. Yasuda T, Bundo K, Hino A, Honda K, Inoue A, Shirakata M, Osawa M, Tamura T, Nariuchi H, Oda H, Yamamoto T, Yamanashi Y, (2007) Dok1 and Dok2 are negative regulators of T cell receptor signaling. Int Immunol 19: 487-495
38. Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G, (2008) Immunological aspects of cancer chemotherapy. Nat Rev Immunol 8: 59-73